Drug recall · August 28, 2019
Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection for IV or IM Use recall
Why: Lack of Assurance of Sterility.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection for IV or IM Use (concentration = 10 mg/mL), 6 mL Syringe, Rx Only, SCA Pharmaceuticals, Windsor, CT 06095, NDC 70004-0430-09.
- Lots / codes
Lot #: 1219010961, Exp. 10/24/2019
- Quantity
- 922 syringes
- Company
- SCA Pharmaceuticals, LLC, Windsor, CT
- Distribution
- Nationwide in the U.S.
- Initiated
- August 16, 2019 · Voluntary: Firm initiated
- Classified
- August 26, 2019
- Reported
- August 28, 2019
- Ended
- October 15, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ketamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.